- Investing Ideas
- /
- US Artificial Intelligence (AI) Powered Medical Diagnosis Stocks
US Artificial Intelligence (AI) Powered Medical Diagnosis Stocks
Results
23
AI is revolutionizing medical diagnosis by leveraging advanced machine learning and data analytics to achieve unprecedented accuracy and speed. Trained on massive datasets of medical images, lab results, and patient histories, AI systems can detect conditions like cancer, heart disease, or neurological disorders earlier and more reliably than traditional methods, often spotting subtle patterns that elude human clinicians. For example, AI-powered tools are already surpassing radiologists in identifying tumors on X-rays or MRIs, reducing misdiagnoses and enabling earlier interventions. Beyond imaging, AI integrates real-time data from wearables—such as heart rate or glucose levels—to flag anomalies instantly, shifting diagnosis from reactive to proactive. While challenges like data quality and regulatory approval persist, AI’s diagnostic prowess promises to make healthcare more precise and timely, potentially saving countless lives through swift, accurate detection.
23 companies
Medtronic
Market Cap: US$105.0b
Develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
MDT
US$85.28
7D
-4.0%
1Y
3.6%
Tempus AI
Market Cap: US$6.4b
Operates as a healthcare technology company.
TEM
US$43.79
7D
-12.2%
1Y
n/a
Lantheus Holdings
Market Cap: US$6.4b
Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.
LNTH
US$100.16
7D
2.8%
1Y
67.3%
Guardant Health
Market Cap: US$4.9b
A precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.
GH
US$43.87
7D
0.9%
1Y
129.6%
RadNet
Market Cap: US$3.5b
Provides outpatient diagnostic imaging services in the United States and internationally.
RDNT
US$53.59
7D
2.1%
1Y
10.4%
Cosmo Pharmaceuticals
Market Cap: US$723.1m
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
CMOP.F
US$62.80
7D
0%
1Y
-17.4%
Cosmo Pharmaceuticals
Market Cap: CHF 723.1m
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPNZ
CHF 45.25
7D
-17.6%
1Y
-35.4%
Veradigm
Market Cap: US$678.3m
A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.
MDRX
US$4.15
7D
-2.4%
1Y
-47.8%
CeriBell
Market Cap: US$608.7m
Operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.
CBLL
US$19.23
7D
-0.05%
1Y
n/a
Guerbet
Market Cap: €327.8m
Engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions.
GBTP
€30.03
7D
0%
1Y
n/a
Nano-X Imaging
Market Cap: US$261.4m
Develops a commercial-grade tomographic imaging device with a digital X-ray source.
NNOX
US$4.51
7D
-8.1%
1Y
-56.1%
Light AI
Market Cap: US$49.6m
A healthcare company, focuses on developing artificial intelligence health diagnostic solutions.
OHCF.F
US$0.30
7D
-28.6%
1Y
n/a
Renalytix
Market Cap: US$24.8m
Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management kidney diseases in the United States.
RENX.F
US$0.091
7D
0%
1Y
n/a
Renalytix
Market Cap: US$24.8m
Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management kidney diseases in the United States.
RNLX.Y
US$0.20
7D
0%
1Y
-76.6%
Spectral AI
Market Cap: US$30.1m
An artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States.
MDAI
US$1.25
7D
-3.1%
1Y
-41.9%
Acarix
Market Cap: US$235.6m
A medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out.
ACIX.F
US$0.009
7D
-67.2%
1Y
n/a
OneMedNet
Market Cap: US$15.1m
Provides clinical imaging solutions.
ONMD
US$0.52
7D
-4.0%
1Y
-19.0%
America Great Health
Market Cap: US$10.6m
Operates as a biotechnology company in the United States.
AAGH
US$0.0005
7D
0%
1Y
-74.1%
TrivarX
Market Cap: US$7.9m
A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.
MDBI.F
US$0.0021
7D
0%
1Y
n/a
IQ-AI
Market Cap: US$2.7m
Through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States.
IQAI.F
US$0.02
7D
0%
1Y
n/a
HeartSciences
Market Cap: US$3.1m
A medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility.
HSCS
US$3.05
7D
8.9%
1Y
-72.7%
Aspira Women's Health
Market Cap: US$2.7m
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States.
AWH
US$0.098
7D
-8.0%
1Y
-97.0%
EvokAI Creative Labs
Market Cap: US$874.6k
A MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector.
OKAI.F
US$0.17
7D
0%
1Y
n/a